These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3509540)

  • 1. Ro 15-8075 (cefetamet pivoxyl), a new oral cephalosporin: in vitro activity of the free acid Ro 15-8074 and regression line analyses.
    Grimm K; Grimm H
    Chemioterapia; 1987 Jun; 6(2 Suppl):84-7. PubMed ID: 3509540
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in vitro antibacterial activities of cefetamet (Ro 15-8074/005), a new oral cephalosporin, and eight other oral antimicrobials.
    Rozgonyi F; Papp-Falusi E; Varga J; Rozgonyi-Szitha K
    J Chemother; 1989 Jul; 1(4 Suppl):119-22. PubMed ID: 16312332
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Sep; 25(9):1796-9. PubMed ID: 3654953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
    Chau PY; Leung YK; Ng WW; Arnold K
    Antimicrob Agents Chemother; 1987 Mar; 31(3):473-6. PubMed ID: 3579264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of cefetamet compared with other antimicrobial agents against bacteria isolated from respiratory tract infections].
    Mendes CM
    Rev Assoc Med Bras (1992); 1997; 43(1):47-52. PubMed ID: 9224992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial spectrum of Ro 15-8074/001, a new oral cephalosporin.
    Thomas MG; Lang SD
    Antimicrob Agents Chemother; 1986 May; 29(5):945-7. PubMed ID: 3729354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of cefetamet (Ro 15-8074).
    Mittermayer H
    Eur J Clin Microbiol; 1986 Oct; 5(5):530-4. PubMed ID: 3490975
    [No Abstract]   [Full Text] [Related]  

  • 8. In-vitro activity of cefetamet (Ro 15-8074) compared with other oral agents.
    Rozgonyi F; Papp-Falusi E; Varga J; Rozgonyi-Szitha K
    J Antimicrob Chemother; 1989 Oct; 24(4):539-46. PubMed ID: 2613603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of cefpodoxime, an oral 3rd generation cephalosporin.
    Raymond N; Lang S
    N Z Med J; 1993 Feb; 106(949):44. PubMed ID: 8464593
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of Ro 236240, Ro 158074 and Ro 195247 against resistant gonococci.
    Easmon CS; Woodford N; Ison CA
    Chemioterapia; 1987 Jun; 6(2 Suppl):156. PubMed ID: 3151337
    [No Abstract]   [Full Text] [Related]  

  • 11. In-vitro activity of FK-037, a new parenteral cephalosporin.
    Jones RN; Barrett MS; Erwin ME
    J Antimicrob Chemother; 1994 Jan; 33(1):137-44. PubMed ID: 8157554
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of the oral cephalosporin cefetamet pivoxyl (Ro 15-8075) and its microbiologically active metabolite cefetamet (Ro 15-8074).
    Koup J; Stoeckel K; Dubach U
    Chemioterapia; 1987 Jun; 6(2 Suppl):277-9. PubMed ID: 3509962
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of uncomplicated urinary infections with a single dose of Ro 15-8075 cefetamet pivoxyl.
    Walhor F; Mbuyamba P; Cerstelotte E; Lambin A; Stenier P
    J Chemother; 1989 Jul; 1(4 Suppl):849-50. PubMed ID: 16312667
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antimicrobial activity of cefetamet against clinically isolated microbial strains collected from urban RTI patients].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y
    Jpn J Antibiot; 1992 Nov; 45(11):1451-9. PubMed ID: 1494228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cefaclor, cefetamet and Ro 40-6890 on inflammatory responses of human granulocytes.
    Scheffer J; Knöller J; Cullmann W; König W
    J Antimicrob Chemother; 1992 Jul; 30(1):57-66. PubMed ID: 1429337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftizoxime (FK749), a new cephalosporin with a potent in-vitro activity against Gram-negative bacilli.
    Ogawa M; Hama M; Takata N; Kosaki G; Suginaka H
    J Antimicrob Chemother; 1981 Jun; 7(6):673-6. PubMed ID: 6941959
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative in vitro activity of cefetamet and fleroxacin against anaerobic bacteria.
    Wüst J; Hardegger U
    Eur J Clin Microbiol; 1987 Dec; 6(6):688-90. PubMed ID: 3126062
    [No Abstract]   [Full Text] [Related]  

  • 18. Cefetamet pivoxil: bacteriostatic and bactericidal activity of the free acid against 355 gram-negative rods.
    Hohl P; von Graevenitz A; Zollinger-Iten J
    Infection; 1988; 16(3):194-8. PubMed ID: 3403040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of Ro 09-1428, a novel cephalosporin with a catechol moiety.
    Qadri SM; Ayub A; Ueno Y; Saldin H
    Clin Ther; 1992; 14(4):562-9. PubMed ID: 1525790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentric study to evaluate efficacy and safety of cefetamet pivoxyl in lower respiratory tract infections in Indian patients.
    Badyal DK; Dhanoa J; Dadhich AP; Athavale AU; Joshi S; Solanki B; Mukherjee CR; Saran M; Bazaz T
    J Indian Med Assoc; 2003 Jul; 101(7):436, 438. PubMed ID: 14748382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.